Sunetra Biswas

Sunetra Biswas is currently the Senior Director and Program Lead at Kyverna Therapeutics where she is responsible for leading a pre-IND phase development program team as well as the activities, actions, and strategy from the preclinical stage through commercialization. Her experience includes working on the early phase development and commercialization of YESCARTA and TECARTUS and at Kite as well as supporting the CMC process and analytical development for a registrational trial for TIL therapy at Instil Bio. Sunetra has an undergraduate Bachelor of Pharmacy degree for University of Mumbai and earned an MS in Pharmaceutical Science and Pharmacology from Northeastern University and PhD in Cellular and Molecular Biology from Johns Hopkins School of Medicine, specializing in viral oncology.